Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
McAvoy will be responsible for financial strategies, financial activities, and financial management contributing to the company’s growth strategy.
March 12, 2024
By: Kristin Brooks
Managing Editor, Contract Pharma
FUJIFILM Diosynth Biotechnologies, a contract development and manufacturing organization (CDMO) for biologics, vaccines, advanced therapies and oncolytic viruses, has appointed Richard McAvoy, currently the Holly Springs, NC site head and vice president of business support, as chief financial officer effective April 1, 2024. McAvoy will be responsible for the company’s financial strategies, overseeing financial activities, and financial management contributing to the company’s growth strategy. McAvoy will be based in Holly Springs. McAvoy brings extensive experience to his new global position as CFO, most recently serving as site head for the company’s $2 billion large-scale cell culture manufacturing facility in Holly Springs, poised to be the largest CDMO in North America once completed. Previously he held key roles within the company as global CAPEX counsel and head of business support. Prior to joining the company, he held leadership roles at Novo Nordisk and Alston & Bird LLP. “I’m thrilled to congratulate Richard on his new role. We look forward to Richard’s contributions as we execute on our growth strategy,” said Lars Petersen, president and chief executive officer of FUJIFILM Diosynth Biotechnologies. “His proven leadership driving a People First and Partners for Life mindset with our major clients and solid track record of leading in a landscape of highly complex stakeholders, will contribute to the continued success and growth of our company.” “I am honored to be appointed to the role of CFO at FUJFILM Diosynth Biotechnologies and contribute to the success of this dynamic organization,” said McAvoy. “This company has a rich history and an extremely bright future. I look forward to working collaboratively with our talented team and driving financial strategies that support our near-and-long-term objectives.” Jordan Ulrich, vice president of project delivery, has been appointed interim site head of Holly Springs, effective April 1. Ulrich has been instrumental in initiating and driving the Holly Springs expansion and will ensure a stable delivery of the site towards its completion. McAvoy will succeed Michael Lyons, who has been appointed senior vice president, deputy head of the Small-Scale Business Unit effective April 1.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !